Firstcall Research's report on Poly Medicure
Poly Medicure’s net profit jumps to Rs. 119.32 million against Rs. 110.60 million in the corresponding quarter ending of previous year, an increase of 7.88%. Revenue for the quarter rose by 21.25% to Rs. 973.56 million from Rs. 802.93 million, when compared with the prior year period. Reported earnings per share of the company stood at Rs. 5.41 a share during the quarter as against Rs. 5.02 over previous year period. Profit before interest, depreciation and tax is Rs. 261.13 million as against Rs. 169.12 million in the corresponding period of the previous year.
OUTLOOK AND CONCLUSION
At the current market price of Rs. 487.70, the stock P/E ratio is at 17.54 x FY15E and 19.33 x FY16E respectively.
Earnings per share (EPS) of the company for the earnings for FY15E and FY16E are seen at Rs. 27.80 and Rs. 25.23 respectively.
Net Sales and PAT of the company are expected to grow at a CAGR of 20% and 32% over 2013 to 2016E respectively.
On the basis of EV/EBITDA, the stock trades at 11.43 x for FY15E and 9.88 x for FY16E.
Price to Book Value of the stock is expected to be at 5.23 x and 4.12 x respectively for FY15E and FY16E.
"We recommend ‘BUY’ in this particular scrip with a target price of Rs 550 for Medium to Long term investment", says Firstcall Research Report.
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
